Javier
Raboso Gallego
Novartis (Sweden)
Täby, SueciaPublications in collaboration with researchers from Novartis (Sweden) (1)
2022
-
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
Cancer research, Vol. 82, Núm. 6, pp. 1098-1109